Epidarex Capital

cb Email

Status

ACTIVE

Global HQ

Edinburgh, United Kingdom

Countries of investment

United Kingdom
United States

Investment stages

Seed
Series A
Series B

Industries

Biotechnology
MedTech

About
Epidarex Capital focuses on investing in life-science companies that emerge from under-ventured regions in the US and Europe. The firm targets medtech, therapeutics, and diagnostics companies with the potential for significant impact. Epidarex provides both capital and strategic support, helping these companies transition from early-stage R&D to commercial success. By focusing on underfunded hubs, Epidarex is able to identify hidden gems in the life sciences sector and help them scale to global markets.

Min check size: $100K
Max check size: $30M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Epidarex Capital’s thesis centers on investing in under-ventured regions in the US and Europe to build world-class life science companies. It targets early-stage medtech, therapeutics, and diagnostics startups with strong scientific foundations and global commercialization potential. Epidarex aims to unlock hidden innovation ecosystems by pairing local expertise with international capital.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock